POSTER SESSION IV
Tuesday, March 10, 2009 — 1:00 PM - 4:30 PM
Hynes CC Exhibit Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GYNECOLOGIC PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
152
Relationship of Underreporting of Placental Abnormalities to Clinical Diagnosis
(1079)
FE Sharkey - University of Texas Health Science Center, San Antonio, TX
Clinical Outcomes of Pregnant Women with Fetomaternal Hemorrhage Detected by Flow Cytometry
(1103)
Y Zhang, SY Yasin, P Ruiz - University of Miami, Miami, FL
Role of Hofbauer Cells in Vasculogenesis of Chorionic Villi: Comparative Study in Normal Placentas, Complete Hydatidiform Moles, and Chorangioma
(1000)
J-H Jo, JE Hwang, BH Park, K-R Kim - University of Ulsan College of Medicine, Seoul, Republic of Korea
HSD3B1 Is a Specific Trophoblast-Associated Marker Not Expressed in Various Normal and Neoplastic Tissues
(1032)
TL Mao, W Huang, YM Jeng - National Taiwan University Hospital, Taipei, Taiwan; Abnova Cooperation, Taipei, Taiwan
Chromosome In Situ Hybridization To Differentiate Early Partial Hydatidiform Mole from Hydropic Abortus: A Validation Study
(972)
AK Folkins, LZ Cruz, DP Goldstein, RS Berkowitz, CP Crum, DW Kindelberger - Brigham and Women's Hospital, Boston, MA
Diagnosis and Subclassification of Hydatidiform Moles Utilizing p57 Immunohistochemistry and Molecular Genotyping: Validation and Prospective Analysis with Development of an Algorithmic Approach
(1037)
TG McConnell, K Murphy, M Hafez, RS Vang, BM Ronnett - Johns Hopkins Medical Institutions, Baltimore, MD
Tissue DNA Genotyping of Hydatidiform Moles: Practical and Reliable Diagnosis
(1024)
F Lipata, M Martel, LH Hao, V Parkash, P Hui - Yale University School of Medicine, New Haven, CT
Clinical Significance of Distinguishing Homozygous from Heterozygous Complete Hydatidiform Mole
(1006)
ME Klein, JD Pfeifer, BA Zehnbauer, AL Stephens, PC Huettner - Washington University Medical Center, St. Louis, MO
Expression of PTEN and MUC4 May Help Predict Disease Progression in Patients with Endometriosis
(980)
MM Gondra, SM Lele, K Martin, SK Batra, S Johansson, JS Davis, S Remmenga - University of Nebraska Medical Center, Omaha, NE
Mass-Forming Endometriosis Shows HMGA1 and HMGA2 Rearrangements
(1040)
F Medeiros, ARC Araujo, M Erickson-Johnson, PC Kashyap, CP Crum, M Nucci, P Dal Cin, X Wang, DA Bell, AM Oliveira - Mayo Clinic, Rochester, MN; Hospital Universitario Onofre Lopes, Natal, RN, Brazil; Brigham and Women's Hospital, Boston, MA
Calretinin and B72.3 as Useful Markers in the Differential Diagnosis of Adenocarcinoma Versus Reactive Mesothelium in a Background of Adnexal Endometriosis
(1050)
TR Pal, ZJ Schreiber, J Liu, C Tornos - Stony Brook University Medical Center, Stony Brook, NY
Adenomatoid Tumors of the Female and Male Genital Tracts: A Morphological and Immunohistochemical Study of 34 Cases
(1074)
AR Sangoi, EJ Schwartz, JK McKenney, RV Rouse, TA Longacre - Stanford University, Stanford, CA
Expression of D2-40, a Marker of Mesothelial and Lymphatic Endothelial Differentiation, in Adenomatoid Tumors: A Potential Diagnostic Pitfall in Distinguishing from Lymphatic Tumors
(1035)
SJ McAlhany, JT Rabban - University of California San Francisco, San Francisco, CA
Neuronal Elements within Gliomatosis Peritonei: Immunohistochemical Evidence of an Under-Recognized Feature
(992)
AY Huang, AW Bollen, CJ Zaloudek - UCSF, San Francisco, CA
Thyroid Transcription Factor-1 Expression in Benign Gynecologic Tissues
(1045)
H Niu, VA LiVolsi, TL Pasha, PJ Zhang - Guangzhou Children's Hospital, Guangzhou, China; Hospital of University of Pennsylvania, Philadelphia, PA
Regulation of Toll-Like Receptors in Cancer Stemness: A Pro-Inflammatory Switch Model
(976)
M Gallagher, S Elbaruni, R Flavin, C Martin, A Laios, S O'Toole, O Sheils, JJ O'Leary - Trinity College Dublin, Dublin, Ireland
Mucinous Change of the Fallopian Tube in Patients with Appendiceal or Ovarian Mucinous Tumors
(1099)
AK Wong, DA Barbuto, LW McPhaul, EG Silva - Cedars-Sinai Medical Center, Los Angeles, CA; Harbor-UCLA, Los Angeles, CA
Ovarian Stroma and Adenofibroma in Fallopian Tubes of Women Undergoing BRCA Prophylactic Salpingo-Oophorectomy
(1094)
AE Walts, I Cass, D Barbuto - Cedars-Sinai Medical Center, Los Angeles, CA
Novel Model Systems To Study the Fallopian Tube Secretory Epithelium - The Cell-of-Origin of Serous Pelvic Carcinoma
(1022)
K Levanon, AK Folkins, RI Drapkin - Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA
The DNA Damage Response of Fallopian Tube Secretory Epithelial Cells Renders Them Susceptible to Carcinogenesis
(1021)
K Levanon, V Ng, MC Chang, PD Vermeer, JL Zabner, CP Crum, RI Drapkin - Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital, Boston, MA; University of Iowa, Iowa City, IA
An Early Precursor to Pelvic Serous Carcinoma (p53 Signature): Site Specificity and Impact of Genetic Risk
(951)
MC Chang, AK Folkins, EA Jarboe, A Saleemuddin, Y Lee, CP Crum - Brigham & Women's Hospital, Boston, MA
Contrasts in Pathologic Presentation between Symptomatic and Asymptomatic BRCA Mutation-Associated Pelvic Cancer: One or Two Diseases?
(1076)
S Schulte*, AK Folkins*, MH Roh, EA Jarboe, JL Hecht, CP Crum - Brigham and Women's Hospital, Boston, MA
High Grade Serous and Endometrioid Carcinomas: A Convergence of Two Pathways in Pelvic Cancer Differentiation?
(1067)
MH Roh, Y Yassin, A Miron, CP Crum, MS Hirsch - Brigham and Women's Hospital, Boston, MA; Dana Farber Cancer Institute, Boston, MA
Multiple Deep Level Sections of Tubal Fimbriae Blocks in Risk Reducing Salpingo-Oophorectomy from Women with BRCA Mutations: Do Levels Increase Detection of Occult Cancer?
(1012)
EF Krasik, CB Powell, LM Chen, B Crawford, CJ Zaloudek, JT Rabban - UCSF, San Francisco, CA
Evidence-Based Recommendations for Intra-Operative Pathologic Evaluation of Risk Reducing Salpingo-Oophorectomies from Women with BRCA Mutations
(1029)
AN Mackey, LM Chen, CB Powell, B Crawford, CJ Zaloudek, JT Rabban - UCSF, San Francisco, CA
The Incidence of Fallopian Tube Primaries Reaches 15% of All Adnexal Tumors When Standardized Grossing Protocols Are Followed
(1098)
R Wilcox, K Gwin, A Montag - University of Chicago, Chicago, IL
button next to any title to add to Itinerary Planner...
Add
